Drug Repurposing for Pandemic Innovation: Establishing an Effective and Efficient Ecosystem Effective treatments for both existing and emerging diseases may already be available on pharmacy shelves. Many approved drugs...
June 12, 2023 Fosfomycin for Non-Urinary Tract Infections: a systematic review Although fosfomycin is currently approved for treating urinary tract infections, it is increasingly being used as salvage...
June 7, 2023-June 8, 2023 Rare Disease Endpoint Advancement Pilot Program Workshop: Novel Endpoints for Rare Disease Drug Development Panel within a virtual workshop presented by The Duke-Margolis Center for Health Policy, under a cooperative agreement with the U.
May 4, 2023 Results of the 2022 global WHO online survey on diagnostic capacities and treatment practices for implantation (deep) mycoses Barbara Milani (WHO consultant), under the guidance of Daniel Argaw Dagne (WHO Department of Control of Neglected Tropical...
May 4, 2023 A Path to Real-World Evidence in Critical Care Using Open-Source Data Harmonization Tools COVID-19 highlighted the need for use of real-world data (RWD) in critical care as a near real-time resource for clinical...
April 24, 2023 Leveraging Biolink as a “Rosetta Stone” Between C-Path and EJP-RD Semantic Models Provides Emergent Interoperability
March 29, 2023 C-Path Appoints Key Scientific Leaders to Executive Roles Critical Path Institute (C-Path) announced today the appointment of three accomplished leaders to key executive roles within the..
March 16, 2023 Efficacy of Cefoperazone Sulbactam in Patients with Acinetobacter Infections: A Systematic Review of the Literature According to the latest guidelines by the Infectious Disease Society of America (IDSA), there is no defined standard of care for..
March 8, 2023 Establishing a Basis for Secondary Use Standards for Clinical Trials Study seeks to understand how different forms of data meet the needs of researchers.